The JV is funded by Boehringer Ingelheim as lead investor with 30 million EUR and by Evotec and bioMérieux with 5 million EUR each.
Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
We must try to make the health care system more accessible for people with disabilities
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Subscribe To Our Newsletter & Stay Updated
